Liver Cancer and Immunotherapy in the Liquid Biopsy Era

Clinical trial NCT05810402 · RECRUITING

Trial details

NCT number: NCT05810402
Sponsor: University Hospital, Montpellier
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Hepatocellular Carcinoma BCLC Stage B Hepatocellular Carcinoma BCLC Stage C Hepatocellular Carcinoma Immune Checkpoint Inhibitor Liquid Biopsy

Start date: 2023-06-28
Primary completion: 2026-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.